Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Coloplast A/S
A/S
Active
CVR 69749917
Holtedam 1, 3050
Humlebæk
Manufacture of medical and dental instruments and supplies
·
NACE 3250
Est. 1957 · 68 years old
1.492 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of medical and dental instruments and supplies
/
Coloplast A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
24B
18B
12B
5.9B
-0.0B
2021: 14B
14B
2021
2022: 15B (+5% vs 2021)
15B
+5%
2022
2023: 15B (+6% vs 2022)
15B
+6%
2023
2024: 16B (+4% vs 2023)
16B
+4%
2024
2025: 19B (+18% vs 2024)
19B
+18%
2025
EBITDA
DKK millions
5.9B
4.4B
2.9B
1.5B
0B
2021: 4.7B
4.7B
2021
2022: 4.4B (-8% vs 2021)
4.4B
-8%
2022
2023: 3.6B (-18% vs 2022)
3.6B
-18%
2023
2024: 3.7B (+3% vs 2023)
3.7B
+3%
2024
2025: 3.9B (+6% vs 2024)
3.9B
+6%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Revenue
18.900.000
16.032.000
15.410.000
14.548.000
13.822.000
Staff expenses
-662.000
-135.000
-311.000
-864.000
-644.000
EBITDA
3.946.000
3.709.000
3.599.000
4.368.000
4.737.000
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
3.946.000
3.709.000
3.599.000
4.368.000
4.737.000
Net financials
-2.119.000
-324.000
399.000
502.000
989.000
Profit before tax
1.827.000
3.385.000
3.998.000
4.870.000
5.726.000
Tax
649.000
698.000
804.000
908.000
995.000
Net profit
1.178.000
2.687.000
3.194.000
3.962.000
4.731.000
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
36.573.000
38.473.000
52.860.000
27.844.000
11.600.000
Equity
7.531.000
11.783.000
13.797.000
6.344.000
7.031.000
Long-term debt
21.820.000
17.894.000
17.438.000
16.560.000
0
Short-term debt
7.220.000
8.794.000
21.529.000
4.769.000
4.213.000
Total debt
29.040.000
26.688.000
38.967.000
21.500.000
4.213.000
Financial ratios
5-year trend
EBITDA margin
20,9 %
This company
15,8 %
Market median
This company
Market median
32% above market
2021
2025
Equity ratio
20,6 %
This company
38,2 %
Market median
This company
Market median
46% below market
2021
2025
Return on equity
15,6 %
This company
18,4 %
Market median
This company
Market median
15% below market
2021
2025
Net profit margin
6,2 %
This company
8,1 %
Market median
This company
Market median
23% below market
2021
2025
Asset turnover
0,52×
This company
1,12×
Market median
This company
Market median
54% below market
2021
2025
Debt / equity
3,86×
This company
0,62×
Market median
This company
Market median
523% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
View
PDF
More on Coloplast A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
